Genvea Biosciences Introduces packaged solutions for Drug Discovery, Agricultural Informatics and Viral/ Vaccine Research.

The Drug Discovery Enterprise Edition (DDEE) is a dedicated and fully integrated workbench for data-driven drug discovery, providing modular tools to facilitate a holistic systems biology approach.
The DDEE integrates relevant public datasets pertinent in any drug discovery pipeline, a wide range of high-throughput in silico analysis procedures and visualization in a highly tractable environment. The Edition is built into a customized, ready-to-use hardware system, with integrated storage and high-speed processors to provide for maximum throughput and productivity.
 

Genvea is sponsor and exhibitor at the Intelligent Systems in Molecular Biology (ISMB) convention in Brisbane. Genvea presented its range of services and consultancy, launched its Australian operations at ISMB 2003, Brisbane and established linkages with new developers and consultants.

 

Custom solutions that were showcased included the Drug Discovery Enterprise Edition, and the SARS Bioinformatics Workbench, a custom solution introduced to meet customer specification within two weeks of the crisis. The SARS Bioinformatics Workbench (BW) delivers the world’s only dedicated and fully integrated workbench for bioinformatics-based research on the SARS virus.

 
The SARS BW is designed to provide an effective and productive foundation for identifying immunogenic targets, by utilizing genome informatics resources along with best-of-breed bioinformatics techniques. The SARS BW already integrates all relevant public datasets, a wide range of high-throughput in silico analysis procedures and visualization in a highly tractable environment.